Literature DB >> 18989242

Technique and outcomes of pulmonary endarterectomy surgery.

Patricia A Thistlethwaite1, Kan Kaneko, Michael M Madani, Stuart W Jamieson.   

Abstract

Pulmonary endarterectomy (PTE) is the definitive treatment for chronic pulmonary hypertension resulting from thromboembolic disease. Chronic thromboembolic pulmonary hypertension is estimated to occur in approximately 4% of patients who have developed an acute pulmonary embolism, though the true prevalence is suspected to be much higher. Chronic thromboembolic pulmonary hypertension is characterized by intraluminal thrombus organization, fibrous stenosis, and vascular remodeling of pulmonary vessels. PTE is an operation considered to be a curative for this affliction and is therefore superior to transplantation. The procedure involves the removal of organized and incorporated fibrous obstructive tissue from the pulmonary arterial tree and is a true endarterectomy, not an embolectomy. Surgical outcomes with respect to functional status, quality of life, hemodynamics, right ventricular function, and gas exchange are favorable. Preoperative hemodynamic severity and site of anatomical obstruction are key predictors of postoperative outcome. This article focuses on the surgical techniques and outcomes of patients undergoing PTE for chronic thromboembolic pulmonary hypertension and discusses the currently known factors that affect survival after this operation.

Entities:  

Mesh:

Year:  2008        PMID: 18989242

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  34 in total

1.  Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy.

Authors:  Kim M Kerr; William R Auger; James J Marsh; Gehan Devendra; Roger G Spragg; Nick H Kim; Richard N Channick; Stuart W Jamieson; Michael M Madani; Gerard R Manecke; David M Roth; Gordon P Shragg; Peter F Fedullo
Journal:  Chest       Date:  2011-08-11       Impact factor: 9.410

2.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Left ventricular strain and strain rate by 2D speckle tracking in chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy.

Authors:  Nicholas Olson; Jason P Brown; Andrew M Kahn; William R Auger; Michael M Madani; Thomas J Waltman; Daniel G Blanchard
Journal:  Cardiovasc Ultrasound       Date:  2010-09-27       Impact factor: 2.062

4.  Pulmonary endarterectomy surgery--a technically demanding cure for WHO Group IV Pulmonary Hypertension: requirements for centres of excellence and availability in Canada.

Authors:  John J Ryan; Stuart Rich; Stephen L Archer
Journal:  Can J Cardiol       Date:  2011-10-22       Impact factor: 5.223

5.  Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.

Authors:  John E Cannon; Li Su; David G Kiely; Kathleen Page; Mark Toshner; Emilia Swietlik; Carmen Treacy; Anie Ponnaberanam; Robin Condliffe; Karen Sheares; Dolores Taboada; John Dunning; Steven Tsui; Choo Ng; Deepa Gopalan; Nicholas Screaton; Charlie Elliot; Simon Gibbs; Luke Howard; Paul Corris; James Lordan; Martin Johnson; Andrew Peacock; Robert MacKenzie-Ross; Benji Schreiber; Gerry Coghlan; Kostas Dimopoulos; Stephen J Wort; Sean Gaine; Shahin Moledina; David P Jenkins; Joanna Pepke-Zaba
Journal:  Circulation       Date:  2016-04-06       Impact factor: 29.690

6.  Ramelteon for Prevention of Postoperative Delirium: A Randomized Controlled Trial in Patients Undergoing Elective Pulmonary Thromboendarterectomy.

Authors:  Stuti J Jaiswal; Anuja D Vyas; Andrew J Heisel; Haritha Ackula; Ashna Aggarwal; Nick H Kim; Kim M Kerr; Michael Madani; Victor Pretorius; William R Auger; Timothy M Fernandes; Atul Malhotra; Robert L Owens
Journal:  Crit Care Med       Date:  2019-12       Impact factor: 7.598

7.  Prediction of hemodynamic improvement after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension using non-invasive imaging.

Authors:  Bastiaan E Schölzel; Martijn C Post; Alexander van de Bruaene; Steven Dymarkowski; Wim Wuyts; Bart Meyns; Werner Budts; Marion Delcroix
Journal:  Int J Cardiovasc Imaging       Date:  2014-08-22       Impact factor: 2.357

8.  Reduced force of diaphragm muscle fibers in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Emmy Manders; Peter I Bonta; Jaap J Kloek; Petr Symersky; Harm-Jan Bogaard; Pleuni E Hooijman; Jeff R Jasper; Fady I Malik; Ger J M Stienen; Anton Vonk-Noordegraaf; Frances S de Man; Coen A C Ottenheijm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-17       Impact factor: 5.464

9.  Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension: How can patients be better selected?

Authors:  Juan C Grignola; Enric Domingo
Journal:  World J Cardiol       Date:  2013-03-26

10.  Chronic thromboembolic pulmonary hypertension.

Authors:  Lara M Wittine; William R Auger
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.